Effect of pericapsular nerve group block in patients with hip fracture for spinal anaesthesia positioning

Effect of pericapsular nerve group block in patients with hip fracture for spinal anaesthesia positioning: A randomized controlled study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059919

Enrollment

Registered

2023-11-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Pericapsular nerve group block followed by spinal anaesthesia in patients with hip fracture: Dose -20 ml 0.5% Ropivacaine, route of administration - Ultrasound guided in musculofascial

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I, II, III undergoing elective surgery under spinal anaesthesia. Unilateral hip fracture surgery under spinal anaesthesia Willingness of patient

Exclusion criteria

Exclusion criteria: Age 60 years Patients having any drug allergy. Local site infection Patients having Neuromuscular disorder and neurological symptoms Patients having coagulation disorder Pregnancy Patients having bilateral hip fracture Patient giving negative consent for procedure

Design outcomes

Primary

Measure	Time frame
Pain profile during positioning for Subarachnoid Block after giving PENG blockTimepoint: Pain profile is measured after 30 minutes of giving PENG block	—

Secondary

Measure	Time frame
Best angle obtained for spinal anaesthesia positioning Time to CSF flow(sec) Operator satisfaction Number of trials for subarachnoid block Any side effectsTimepoint: All outcomes mentioned above are measured after 30 minutes of giving PENG block	—

Countries

India

Contacts

Public ContactPrince Bhatia

B.J. Medical College Ahmedabad

drsid25@gmail.com9426332701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026